Update: Pfizer Supply
The province has confirmed a stable supply of adult Pfizer-BioNTech Comirnaty vaccine. Effective immediately the requirement to reserve Pfizer-BioNTech Comirnaty for individuals 12-29 years old has been removed.
As local adult Pfizer BioNTech Comirnaty vaccine supply is expected to increase over the next few weeks, please maintain use of both mRNA vaccines and ensure that inventory of both is managed based on the principles of effectiveness of both vaccines, interchangeability and minimizing waste.
Both the Moderna Spikevax and Pfizer BioNTech Comirnaty vaccines provide excellent protection against severe COVID-19 infection. Several studies have shown that Moderna Spikevax can provide better protection than the Pfizer BioNTech Comirnaty vaccine, especially for older adults and people who have a weak immune system.
Pfizer-BioNTech Comirnaty vaccine is preferentially recommended in individuals 12-29 years of age.
Top
|
|